Stocks were indicated lower after the Greek “no” vote on austerity. The one trend that has prevailed for over three years is that investors have literally bought every single pullback. 24/7 Wall St. reviews dozens of analyst and brokerage reports each morning of the week to find new trading and investing ideas for its readers. Some analyst calls cover stocks to buy, but others are about stocks to sell or avoid.

These are this Monday’s top analyst upgrades, downgrades and initiations.

Epizyme Inc. (NASDAQ: EPZM) was started as Outperform with a price target of $40 (versus a $22.71 close) at RBC Capital Markets. While this is a call to nearly double, Epizyme has a consensus price target of $38.67 and a 52-week range of $15.51 to $40.98.

Goldcorp Inc. (NYSE: GG) was started as Outperform with a price target of $24 (versus a $16.18 close) at Credit Suisse. Goldcorp has a consensus analyst target price of $24.19 and a 52-week range of $15.77 to $29.65.

GoPro Inc. (NASDAQ: GPRO) was started as Neutral with a price target of $60 (versus a $51.75 close) at Goldman Sachs. GoPro has a consensus price target of $69.25 and a 52-week range of $36.10 to $98.47.

Intuitive Surgical Inc. (NASDAQ: ISRG) was downgraded to Underweight from Equal Weight at Morgan Stanley, and the price target was cut to $500 from $560 (versus a $486.29 close). Intuitive Surgical has a consensus price target of $567.88 and a 52-week range of $376.00 to $559.04.

VMware Inc. (NYSE: VMW) Was downgraded to Market Perform from Outperform with a $90 price target (versus a $85.20 close) at FBR Capital Markets. VMware has a consensus analyst target of $96.10 and a 52-week range of $73.65 to $103.86.

ALSO READ: Why Investors and Analysts See AT&T as the Best Carrier Again

Other key analyst upgrades and downgrades this Monday were seen as follows:

Aetna Inc. (NYSE: AET) was downgraded to Market Perform from Outperform at FBR Capital Markets.

Axovant Sciences Ltd. (NASDAQ: AXON) was started as Buy with a target price of $31 (versus a $19.26 close) at Jefferies.

Biotie Therapies Corp. (NASDAQ: BITI) was started as Outperform with a price target of $35 (versus a $18.39 close) at RBC Capital Markets. Stifel also started it as Buy with a $30 price target.

Bunge Ltd. (NYSE: BG) was downgraded to Market Perform from Outperform with a $94.00 (versus a $89.52 close) at BMO Capital Markets.

Celanese Corp. (NYSE: CE) was downgraded to Neutral from Buy to Neutral at UBS.

CIRCOR International Inc. (NYSE: CIR) was downgraded to Sector Weight from Overweight at KeyBanc Capital Markets.

ALSO READ: 5 Oil and Gas Stocks Analysts Want You to Buy Now

Columbia Pipeline Group Inc. (NYSE: CPGX) was started as Buy with a target price of $33 (versus $30.34 close) at UBS.

Chemours Co. (NYSE: CC) was started with an Overweight rating and a $24 price target (versus a $16.51 close) at Barclays.

Chubb Corp. (NYSE: CB) was raised to Outperform from Market Perform at Keefe Bruyette & Woods.

Edwards Lifesciences Corp. (NYSE: EW) was raised to Overweight from Equal Weight with a price target of $168 (versus a $142.45 close) at Morgan Stanley.

EnLink Midstream Partners L.P. (NYSE: ENLK) was started as Buy with a target price of $27 (versus a $22.25 close) at UBS.

Humana Inc. (NYSE: HUM) was downgraded to Neutral from Outperform at Wedbush Securities.

NetSuite Inc. (NYSE: N) was downgraded to Underweight from Neutral with a $79 price target (versus a $91.66 close) at Piper Jaffray.

Penn National Gaming Inc. (NASDAQ: PENN) was reiterated as Buy with a $19 fair value estimate (versus a $18.35 close) at Janney Capital Markets.

ALSO READ: Deutsche Bank Loves 4 High-Yield Utilities

Raptor Pharmaceuticals Corp. (NASDAQ: RPTP) was downgraded to Underperform from Perform with a price target of $8.00 (versus a $15.79 close) at Oppenheimer.

Second Sight Medical Inc. (NASDAQ: EYES) was started as Buy with a $21 price target (versus a $14.05 close) at H.C. Wainwright.

Teekay LNG Partners L.P. (NYSE: TGP) was started as Overweight at JPMorgan.

Union Pacific Corp. (NYSE: UNP) was raised to Outperform at Cowen, noting that the stock’s weakness has gone on enough.

In case you missed last Thursday’s top analyst upgrades and downgrades, they included AT&T, Capstone Turbine, ConAgra Foods, Diamond Offshore Drilling, Hecla Mining and a dozen or so more.

Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.